The music industry must immediately recalibrate its valuation of biopic assets as the Michael Jackson film Michael has officially eclipsed Freddie Mercury’s Bohemian Rhapsody to become the highest-grossing musician biopic of all time. This shift is not merely a box office statistic; it represents a massive capitalization of legacy rights that directly impacts publishers, songwriters, and rights holders who manage the estates of these superstars. With Michael grossing $932.2 million as of Sunday, June 14, the financial weight of Jackson’s catalog has proven more potent in the global theatrical market than Mercury’s, signaling where the next wave of investment in music biographies should flow.
Legacy Assets Outperforming Modern Expectations
While Michael has secured the top spot among musician biopics, it still trails the overall top-grossing biopic, Oppenheimer. Christopher Nolan’s 2023 film about theoretical physicist J. Robert Oppenheimer has grossed $975.8 million worldwide. The data reveals a critical divergence in international market penetration for music films. According to Box Office Mojo figures, international ticket sales account for 61.1% of Michael’s worldwide total, whereas international sales comprised 76.2% of Bohemian Rhapsody’s total. This suggests that while Jackson’s global appeal is immense, the specific demographic driving Mercury’s film had a stronger international footprint. Rights holders must analyze these regional variances to optimize future licensing and distribution strategies for similar legacy projects.
Shared Showmanship and Unfinished Demos
The commercial dominance of these two films stems from the unique, parallel careers of Jackson and Mercury. Both artists rose to fame in groups, The Jackson 5 and Queen, respectively, and are widely regarded as two of the greatest showmen of all time. Their paths crossed in the early 1980s when Jackson attended Queen concerts in Los Angeles. They met for dinner and recorded three demo tracks together that went unfinished. This historical connection adds a layer of depth to the biopic market, proving that audiences are drawn to the human connections between legends. Tragically, both died years before their time; Mercury died in 1991 at age 45 from complications of AIDS, and Jackson died in 2009 at age 50 from cardiac arrest caused by acute propofol intoxication.
Theatrical Productions Fueling Film Revenue
The success of these biopics is reinforced by successful theatrical productions based on both artists’ music. The Queen musical, We Will Rock You, opened on London’s West End in 2002. MJ: The Musical has been a Broadway fixture since December 6, 2021. Graham King, who co-produced Michael with associates John Branca and John McClain, also co-produced Bohemian Rhapsody and Jersey Boys, the story of the Four Seasons. King’s involvement in multiple entries on Billboard’s list of music biopics indicates a producer who understands the specific market for music star narratives.
What to Watch Next
Industry professionals should monitor the trajectory of the remaining 25 biopics on the list, particularly Selena, which grossed $35.8 million, and Shine, which grossed $36 million. The source notes that films about real-life music personalities like Maria von Trapp or Don Shirley were excluded because the subjects are not well-known music stars in their own right. This exclusion criteria confirms that the market for music biopics is strictly tied to the star power of the musical artist, not just the historical figure. Future projects must prioritize artists with established, cult-status musical careers to replicate the financial success of Michael and Bohemian Rhapsody.
SOURCE TYPE: TRADE
For editorial consideration and industry coverage inquiries, contact [email protected]
